Review
Open access
Sep 2026
Advancements in Immunotherapy for Lung Cancer: A Meta‐Analysis of Clinical Trial Outcomes
Immune checkpoint inhibitors (ICIs) have changed therapeutic selections for advanced non–small cell lung cancer (NSCLC). However, comparative evidence versus chemotherapy through ICI monotherapy and chemo‐immunotherapy combination strategies remains incomplete. For this purpose, we conducted a meta‐analysis of randomiz...
Ying-Jie Jiao, Yan Zhao
· Clinical Respiratory Journal · 0 citations